Design and Evaluation of Chitosan-Coated Liposomal Microneedle Capsules for Oral Insulin Delivery: A Proof of Concept

Document Type

Article

Publication Date

2-1-2026

Abstract

The study presents a proof-of-concept for novel protein drug delivery system by formulating layer-coated liposomes with chitosan oligosaccharide (COS) and insulin, infused in dissolvable microneedles (DMNs), and packed in an enteric-coated capsule for oral delivery of insulin. Cellular uptake studies using CCD841 showed time-dependent internalization, while cytotoxicity assays confirmed over 80% cell viability, indicating biocompatibility. The fabricated hydroxypropyl methylcellulose (HPMC) and Aloe vera (AV) based DMN had a pyramidal shape with a height of 464.25 ± 1.48 µm. Permeability studies revealed a sustained release profile in SIF for both layer-coated liposomes (80.08% ± 3.02) and DMN-containing layer-coated liposomes (75.06% ± 1.06). In contrast, a burst release in SGF for layer-coated liposomes and for DMNs is attributed to charge interactions and polymer solubility. Enteric-coated capsules demonstrated no insulin release in SGF for 1 h, indicating effective gastric protection. The release for an enteric-coated capsule containing DMN infused with layer-coated liposomes in SIF reached 79.24% ± 1.22, mirroring the release profile of DMNs. This multilayered system effectively protects insulin from gastric degradation, facilitates delivery of insulin to the intestine, and achieves a sustained release profile, offering a promising strategy for oral insulin delivery.

Keywords

dissolvable microneedle, enteric-coated capsule, insulin, layer-coated liposomes, sustained drug release

Publication Title

Macromolecular Bioscience

ISSN

1616-5187

DOI

10.1002/mabi.202500661

Funders

Ministry of Higher Education, Malaysia (FRGS/1/2021/SKK0/UM/02/7), Universiti Malaya (CORG002-2025)

Volume

26

Issue

2

Publisher

John Wiley and Sons Inc

Share

COinS